drugset / Trial / NCT01404663

Side Effects of Bone Marrow Derived CD133 Transplantation in Cerebral Palsy

NCT01404663 ↗

Phase 1 Completed 12 enrolled Royan Institute
NaSingle-groupOpen-labelTreatment

Summary

Cerebral palsy (CP) is condition, sometimes thought of as a group of disorders that can involve brain and nervous system functions such as movement, learning, hearing, seeing, and thinking.Cerebral palsy is caused by injuries or abnormalities of the brain. Most of these problems occur as the baby grows in the womb, but they can happen at any time during the first 2 years of life, while the baby's brain is still developing.Bone marrow derived stem cells are known as a effective therapy. In this study the investigators evaluate the side effect of bone marrow stem cell transplantation in patients with cerebral palsy.

Timeline

Start
2011-10
Primary completion
2012-04
Completion
2012-05

Drugs

EvaluationDrugModalityDoseRoute
Subject autologous bone marrow-derived CD133(+) cell Cell therapy — Intrathecal

Indications